8-K: 22nd Century Group Secures $20M in New Capital

Sentiment:

Equity Offering


22nd Century Group, Inc. announced a registered direct offering of up to $20 million in Series B Convertible Preferred Stock and Warrants to repurchase Series A Preferred Stock and fund working capital.

Capital raiseThe company is conducting a registered direct offering of up to $20 million in Series B Convertible Preferred Stock and Warrants.An initial closing of approximately $16.0 million is expected on March 24, 2026.A second closing for the remaining $4.0 million is possible within one year, contingent on investor request or company-mandated conditions.The net proceeds from the initial close, after fees and the repurchase of Series A Preferred Stock, are expected to be approximately $5.7 million for working capital.
Worse than expectedThe company is raising capital through dilutive securities (convertible preferred stock and warrants), indicating a need for funds.A significant portion of the proceeds ($9.65 million out of up to $20 million) is allocated to repurchase existing Series A Preferred Stock, suggesting a refinancing or restructuring of prior obligations rather than purely new growth capital.The net proceeds for working capital from the initial close are only $5.7 million, which may be insufficient for substantial growth initiatives given the overall offering size.The alternative conversion price at a 15% discount to VWAP introduces substantial downside risk for existing common shareholders if the stock price declines, leading to greater dilution.

Summary

  • 22nd Century Group, Inc. (XXII) entered into a securities purchase agreement for a registered direct offering of up to $20 million.
  • The offering consists of Series B Convertible Preferred Stock (stated value $1,000 per share) and Warrants to purchase Common Stock.
  • An initial closing of approximately $16.0 million is expected on March 24, 2026.
  • A second closing for the remaining $4.0 million may be requested by investors or required by the company under specific equity conditions within one year of the initial close.
  • The Series B Preferred Stock is convertible into Common Stock at a fixed price of $3.57 or an alternative conversion price of a 15% discount to the lowest daily VWAP over 20 trading days, both subject to a floor price.
  • Warrants are immediately exercisable at $3.57 per share and expire five years after issuance, providing 100% warrant coverage.
  • Net proceeds from the initial close, estimated at $5.7 million after fees and Series A repurchase, will be used to repurchase $9.65 million of outstanding Series A Convertible Preferred Stock and for working capital.
  • The company will pay Dawson James Securities, Inc. a cash fee of 3.0% on the first $9.65 million and 6.0% on the remaining gross proceeds, plus an additional 6.0% on cash exercise of warrants, and up to $35,000 for legal fees.
  • Placement agent warrants for 187,659 shares of Common Stock will be issued with an exercise price of 110% of the Warrants' exercise price.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a necessary but highly dilutive financing event. While it addresses immediate capital needs and refinances existing preferred stock, the terms, particularly the alternative conversion price and warrant coverage, suggest significant potential dilution for common shareholders, indicating financial strain.

Positives

  • Secured up to $20 million in new capital, addressing funding needs.
  • Repurchase of $9.65 million in Series A Convertible Preferred Stock, potentially simplifying the capital structure and reducing future preferred dividend obligations.
  • The Series B Preferred Stock includes anti-dilution protection for future dilutive issuances, protecting investors.
  • The company has the ability to reset the fixed conversion price lower, subject to board approval and a floor price, offering flexibility.
  • Investors funding $2 million or more receive a right of participation in future equity/equity-linked offerings (50% of subsequent financing) for 9 months after Series B is no longer outstanding.

Negatives

  • Significant dilution potential for existing common stockholders due to the conversion features of the Series B Preferred Stock and the exercise of Warrants.
  • The alternative conversion price for Series B Preferred Stock, based on a 15% discount to VWAP, could lead to substantial dilution if the stock price declines.
  • The issuance of placement agent warrants (187,659 shares) adds further potential dilution.
  • The company is prohibited from effecting Variable Rate Transactions while Series B Preferred Stock is outstanding, limiting certain financing options.
  • The Series B Preferred Stock has no established trading market, limiting liquidity for preferred stockholders.
  • The net proceeds for working capital from the initial close are relatively modest at $5.7 million after the Series A repurchase and fees.

Risks

  • Dilution: The issuance of Series B Preferred Stock and Warrants, and their conversion/exercise into Common Stock, will result in significant dilution for existing common stockholders.
  • Market Price Volatility: The alternative conversion price for Series B Preferred Stock is tied to the lowest VWAP, meaning a declining stock price could lead to more shares being issued upon conversion, exacerbating dilution.
  • Liquidity of Series B Preferred Stock: There is no established trading market for the Series B Preferred Stock, which will limit its liquidity.
  • Future Financing Restrictions: Covenants prohibit certain types of Variable Rate Transactions and limit other equity issuances for a period, potentially restricting future capital-raising flexibility.
  • Equity Conditions for Second Close: The company's ability to require the second close is contingent on specific equity conditions (stock price and trading volume), which may not be met.

Future Outlook

The company expects to use the net proceeds to repurchase outstanding Series A Convertible Preferred Stock and for working capital and general corporate purposes. The second closing of the offering is contingent on certain equity conditions and may be requested by investors or required by the company within one year of the initial close.

Management Comments

  • The company expects to use the net proceeds from the Offering to repurchase at par the outstanding Series A Convertible Preferred Stock issued in August 2025 in the amount of $9.65 million, with the balance to be used for working capital and general corporate purposes.

Industry Context

StockSavvy.ai notes that registered direct offerings are a common method for public companies, especially those with smaller market capitalizations or in growth phases, to raise capital efficiently. The use of preferred stock and warrants is typical in such offerings to attract investors by offering enhanced returns and downside protection through conversion features and anti-dilution clauses. The repurchase of Series A Preferred Stock suggests a strategic move to simplify the capital structure or consolidate preferred stock terms under the new Series B.

Comparison to Industry Standards

  • The fixed conversion price of $3.57 and the alternative conversion price at a 15% discount to VWAP are standard mechanisms in convertible securities, offering investors flexibility based on market performance.
  • The 100% warrant coverage is a strong incentive for investors, providing additional upside potential.
  • The beneficial ownership limitation (4.99% or 9.99%) is a common provision to prevent triggering certain regulatory reporting requirements or takeover defenses for large investors.
  • The negative covenants, such as restrictions on indebtedness and Variable Rate Transactions, are typical protections for preferred stockholders, aiming to prevent actions that could further dilute their investment or impair the company's financial health without their consent.
  • The ATM facility limits ($250,000/week, $1.50 min price, 10% daily volume) are within typical parameters for smaller companies utilizing such programs to raise incremental capital without significant market disruption.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
New Preferred Stock DesignationFiling of a Certificate of Designation for Series B Convertible Preferred Stock, outlining its preferences, rights, and limitations.2026-03-20Establishes a new class of preferred stock with specific conversion, voting, liquidation, and redemption rights, impacting the company's capital structure and potentially future financing flexibility.
Stockholder ApprovalStockholder approval obtained for the offering, including the issuance of underlying shares and dilutive issuance provisions.2026-02-20Ensures compliance with Nasdaq listing rules and shareholder mandates for the dilutive financing.
Negative CovenantsProhibition on incurring indebtedness exceeding $100,000 (with exceptions) and issuing senior or pari passu securities to Series B Preferred Stock.2026-03-20Restricts the company's ability to take on significant debt or issue other preferred securities without the consent of Series B holders, protecting their investment but potentially limiting future financial maneuvers.
Prohibition on Variable Rate TransactionsCompany prohibited from effecting or entering into agreements for Variable Rate Transactions while Series B Preferred Stock is outstanding, with limited exceptions for an ATM facility.2026-03-20Protects Series B holders from certain highly dilutive financing structures, but restricts the company's flexibility in raising capital through specific market-dependent mechanisms.

Stakeholder Impact

  • Shareholders (Common Stock): Significant potential for dilution due to the conversion of Series B Preferred Stock and exercise of Warrants, especially with the alternative conversion price mechanism.
  • Series B Preferred Stock Holders: Gain a preferred position in the capital structure with liquidation preference, anti-dilution protection, and participation rights in future financings. They also have a beneficial ownership limitation to manage their stake.
  • Series A Preferred Stock Holders: Their shares will be repurchased at par, providing them with an exit.
  • Creditors: Negative covenants on indebtedness provide some protection by limiting the company's ability to take on excessive new debt senior to or pari passu with the Series B Preferred Stock.
  • Management/Employees: Management equity grants are permitted as an exempt issuance, allowing for continued incentive programs.

Next Steps

  • Initial Close of the Offering expected on March 24, 2026.
  • Company to file a Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of Nevada for the Series B Preferred Stock.
  • Company to file a prospectus supplement with the SEC.
  • Company to apply to list the Series B Preferred Stock and underlying Common Stock on its Trading Market.
  • Investors may request the Second Close for the remaining $4.0 million anytime until the one-year anniversary of the Initial Close.
  • Company may require the Second Close under specific equity conditions until the one-year anniversary of the Initial Close.
  • Company to use net proceeds to repurchase outstanding Series A Convertible Preferred Stock.
  • Company to use remaining balance for working capital and general corporate purposes.

Key Dates

DateDescription
2023-03-31Registration Statement on Form S-3 (No. 333-270473) declared effective by the SEC.
2025-08Issuance date of outstanding Series A Convertible Preferred Stock to be repurchased.
2025-09-30Date of existing indebtedness reflected on the company's balance sheet.
2025-11-04Date of filing of Quarterly Report on Form 10-Q with the Commission.
2025-12-31End of fiscal year for which the company's independent registered public accounting firm will express an opinion on financial statements.
2026-02-20Date of Special Meeting of Stockholders where approval for the offering was obtained.
2026-03-18Date of Engagement Letter with Dawson James Securities, Inc.
2026-03-20Date of Report (earliest event reported) and date of Securities Purchase Agreement.
2026-03-24Expected date of the Initial Close of the Offering.
2027-03-20One-year anniversary of the Initial Close, marking the deadline for the Second Close and the end of the company's right to require it.
2031-03-20Five-year anniversary of the Warrants' issuance date, marking the Termination Date for exercise.

Recommendation

sell

The offering, while providing necessary capital, is highly dilutive for existing common shareholders due to the convertible preferred stock and warrants, especially with the alternative conversion price mechanism. A significant portion of the funds is used to repurchase existing preferred stock rather than solely for growth, and the net working capital injection is relatively small. This suggests ongoing financial challenges and a capital structure that is becoming increasingly complex and potentially burdensome for common equity holders.

Keywords

22nd Century Group, XXII, SEC Filing, 8-K, Securities Purchase Agreement, Registered Direct Offering, Series B Preferred Stock, Convertible Preferred Stock, Warrants, Capital Raise, Dilution, Anti-Dilution, Corporate Finance, Equity Financing, Working Capital, Preferred Stock Redemption

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.